SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001341004-15-000689
Filing Date
2015-09-02
Accepted
2015-09-02 08:13:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FORM SC TO-C scto-c.htm SC TO-C 29397
2 EXHIBIT (A)(5)(A) - PRESS RELEASE exa5-a.htm EX-99 21374
3 valeant.jpg GRAPHIC 9304
4 valeant2.jpg GRAPHIC 6068
  Complete submission text file 0001341004-15-000689.txt   74043
Mailing Address 3845 CORPORATE CENTRE DRIVE O'FALLON MO 63368
Business Address 3845 CORPORATE CENTRE DRIVE O'FALLON MO 63368 636-939-5100
SYNERGETICS USA INC (Subject) CIK: 0000836429 (see all company filings)

IRS No.: 205715943 | Fiscal Year End: 0731
Type: SC TO-C | Act: 34 | File No.: 005-44538 | Film No.: 151088534
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations